CompuGroup Medical Annual General Meeting: Shareholders approve dividend
doubling to EUR 1.00

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM
CompuGroup Medical Annual General Meeting: Shareholders approve dividend
doubling to EUR 1.00

22.05.2024 / 13:43 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

CompuGroup Medical Annual General Meeting: Shareholders approve dividend
doubling to EUR 1.00

* Acts of the governing boards formally approved

* Dividend proposal of EUR 1.00 confirmed

* High approval rates for capital measures

* Focus on data-based solutions and artificial intelligence

Koblenz - The shareholders of CompuGroup Medical SE & Co. KGaA (CGM)
approved the dividend proposal of the General Partner, the Supervisory Board
and the Managing Directors at the e-health group's virtual Annual General
Meeting (AGM) on May 22, 2024. As a result, a dividend of EUR 1.00 per share
will be paid for the financial year 2023, twice as much as in the previous
year. This corresponds to a payout of around EUR 51.7 million. The
shareholders also approved all proposed capital measures by majorities of
more than 90 percent such as the enactment of authorized capital, the
authorization to issue convertible bonds and share options or the
authorization to acquire and use treasury shares.

The shareholders approved the annual financial statements of CompuGroup
Medical SE & Co. KGaA for 2023 and passed the remuneration report for 2023.
The actions of the General Partner of CompuGroup Medical SE & Co. KGaA and
the members of the Supervisory Board were formally approved.

All other items on the agenda were also approved by the shareholders with a
large majority. A total of around 79 percent of the share capital of
CompuGroup Medical SE & Co. KGaA was represented at the Annual General
Meeting. The speeches by CEO Michael Rauch and CFO Daniela Hommel, who has
been in office since February 1, were published beforehand online. A video
replay of both speeches will be made avaailable subsequently on the
company's website.

In his speech, CGM CEO Michael Rauch addressed the 2023 financial year and
the future development of the company. He said: 'The medicine of the future
will be digital, data-based and interconnected. That is why we are focusing
on data-based solutions, Artificial Intelligence, the analysis of medical
data and real-time access. CompuGroup Medical is well prepared for this
future.'

CFO Daniela Hommel introduced herself to CGM's shareholders during her first
AGM speech. With respect to the financials, she emphasized that CompuGroup
Medical is growing organically at a sustainably high level: 'The increase in
revenues and earnings in 2023 contributed to a high free cash flow of EUR
113 million. We have a strong business model. The results confirm the path
that we want to keep pursuing: sustainable profitable growth.'

The complete documents relating to the Annual General Meeting can be found
on our website: Annual General Meeting - Investor Relations - Company -
cgm.com.


---------------------------------------------------------------------------

22.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        CompuGroup Medical SE & Co. KGaA
                   Maria Trost 21
                   56070 Koblenz
                   Germany
   Phone:          +49 (0)160 3630362
   Fax:            +49 (0)261 8000 3200
   E-mail:         investor@cgm.com
   Internet:       www.cgm.com
   ISIN:           DE000A288904
   WKN:            A28890
   Indices:        SDAX, TecDAX
   Listed:         Regulated Market in Frankfurt (Prime Standard);
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Munich, Stuttgart, Tradegate Exchange
   EQS News ID:    1908843

End of News EQS News Service
---------------------------------------------------------------------------

1908843 22.05.2024 CET/CEST